boosting Oncology investigate with built-in KRAS Assay Services and RAS Assays
from the rapidly evolving area of oncology investigation, accurate and productive mutation screening is important for creating targeted therapies. The KRAS products and services System performs a pivotal role in this landscape by giving thorough alternatives for KRAS mutation profiling and analysis. KRAS mutations, present in about ninety five% of